Reaction
Eye Infection Fungal reporting signals
As of the last recalculation, Eye Infection Fungal appears in 374 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 160.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Amphotericin B | 33 | 160.7 | 161.1 |
| Posaconazole Delayed-Release | 26 | 141.5 | 141.9 |
| Voriconazole Injection | 36 | 102.0 | 102.2 |
| Posaconazole | 26 | 95.6 | 95.8 |
| Cenegermin-Bkbj | 18 | 87.0 | 87.1 |
| Moxifloxacin Hydrochloride | 26 | 76.6 | 76.7 |
| Voriconazole | 37 | 75.1 | 75.2 |
| Moxifloxacin | 18 | 74.7 | 74.8 |
| Micafungin Sodium | 11 | 74.4 | 74.5 |
| Ganciclovir | 13 | 73.2 | 73.3 |
| Itraconazole | 13 | 64.1 | 64.2 |
| Prednisolone Acetate | 11 | 60.9 | 61.0 |
| Ganciclovir Sodium | 11 | 59.6 | 59.6 |
| Cefepime | 13 | 52.2 | 52.3 |
| Terbinafine Hydrochloride | 8 | 51.2 | 51.2 |
| Valganciclovir Hydrochloride Powder, | 10 | 46.9 | 46.9 |
| Cefepime Hydrochloride | 13 | 46.5 | 46.5 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 15 | 37.1 | 37.1 |
| Travoprost | 3 | 19.4 | 19.5 |
| Bimekizumab | 5 | 13.2 | 13.2 |
| Droxidopa | 4 | 10.4 | 10.4 |